Articles tagged with Clinical Trials
The MIRO trial found that hybrid minimally invasive esophagectomy (HMIO) significantly reduces postoperative morbidity compared to open oesophagectomy. Long-term results show improved three-year overall survival in the HMIO group, indicating an oncologically sound procedure.
Researchers from Brigham and Women's Hospital are set to present groundbreaking findings on cardiovascular treatment at the ESC Congress 2017. These studies, including CANTOS and RE-DUAL PCI, will provide new insights into the effectiveness of anti-inflammatory therapy and dual antithrombotic therapy in patients with atrial fibrillation.
A new analysis of the FOURIER trial found that very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with fewer cardiovascular events without increased safety risks. The study suggested that lowering LDL-C levels below current guidelines can further reduce recurrent cardiovascular events in high-risk patients.
A study found that transdermal estrogen therapy improved sexual function in early postmenopausal women, but oral conjugated equine estrogens did not show the same benefits. The treatment also reduced pain and increased lubrication compared to placebo.
A large clinical trial found that oxygen therapy did not reduce mortality rates in patients with suspected myocardial infarction. The study enrolled over 6,200 patients and showed no significant difference in mortality rates between those who received oxygen and those who did not.
The University of Arizona College of Medicine - Tucson is part of a team selected for the Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN), a new initiative by the National Institutes of Health. The SIREN grant aims to improve emergency care and clinical outcomes through large multi-site clinical trials.
A clinical trial demonstrates the safety and efficacy of magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) for treating osteoid osteoma, a benign but painful bone tumor in children. The procedure eliminates incisions and ionizing radiation exposure, offering a faster treatment option with improved outcomes.
Three large trials found that screening for type 2 diabetes and cardiovascular risk factors does not reduce mortality in the general population, but individuals diagnosed with diabetes experience reduced mortality rates. The studies suggest that benefits to the general population may be increased by targeting screening to those at grea...
A new meta-analysis finds that plant-based vegetarian diets are linked to lower total cholesterol and reduced risk of heart disease. The study highlights the benefits of a well-planned vegan diet, which can lead to weight loss, lower blood pressure, and improved cardiovascular health.
Researchers have developed and validated a nomogram that can predict overall survival and progression-free survival for patients with oropharyngeal squamous cell carcinoma treated with radiation-based therapy. The nomograms were derived from clinical trials NRG Oncology/RTOG 0129 and 0522.
A recent study published in JAMA found that many studies supporting changes to high-risk medical devices are poorly designed and lack rigor. The researchers analyzed 83 supplement approvals for these devices and found similar problems with data quality and analysis procedures as seen in premarket approval studies.
A study found a nearly 60% increase in exclusion criteria for lung cancer trials from 1986 to 2016, making it difficult to conduct clinical trials. The rise in exclusions is largely due to new medical concerns and complexities with targeted therapies, which are often given in pill form.
Lung cancer clinical trials have complex requirements that act as a barrier to development and patient enrollment. A retrospective study found an increase in eligibility criteria for medical therapy trials, particularly for cardiac, concurrent medications, and immunotherapy-related treatments.
A recent study demonstrates the safety of immunotherapy in treating type 1 diabetes. The treatment showed metabolic effects without accelerating β-cell destruction, suggesting a viable option for patients.
Researchers at Trinity College Dublin advise caution against aggressively lowering blood pressure in older people due to increased risk of falls and blackouts. A recent US trial's results suggest benefits of aggressive treatment may be offset by potential harms, highlighting the need for individualized assessment.
A clinical trial has observed noticeable changes in the behavior of immune systems of type 1 diabetes patients treated with peptides. The treatment has a noticeable effect on the immune system and suggests a potential way to protect remaining beta cells.
A clinical trial has demonstrated the safety and effectiveness of a new treatment using virus-specific cells to treat viral infections in patients who have received a hematopoietic stem cell transplant. The treatment resulted in an overall complete or partial response rate of 92% in patients with severe, drug-resistant viral infections.
A clinical trial at the University of Cincinnati is investigating a drug combination therapy using sirolimus and resveratrol to induce disease remission in patients with lymphangioleiomyomatosis (LAM). The study aims to identify a regimen that will eliminate LAM cells, which currently only suppress growth.
International researchers developed a mathematical model predicting docetaxel discontinuation due to adverse events, incorporating five clinical factors. The combined model stratified patients into low and high risk groups, with the high group having more than double the likelihood of discontinuation.
A study found that ONC201 alters the gene expression of cancer stem cells before killing tumor cells, providing a potential biomarker for response. This effect was not observed in resistant cells, suggesting a predictive gene expression signature may help forecast treatment outcomes.
A new study published in Thorax found that smokers who undergo a low-dose CT scan of their lungs are more likely to quit smoking. The UK Lung Cancer Screening trial involved 4,055 participants and showed a 15% success rate in quitting after two years.
The DAWN trial demonstrates the effectiveness of mechanical thrombectomy for acute stroke caused by large vessel occlusion performed more than 6 hours after onset. The study results offer hope to patients who miss the traditional 6-hour treatment window, allowing doctors to offer life-saving neurointerventional surgery.
A first patient has been successfully treated with the DIALIVE system, a novel liver dialysis device designed to remove toxins that trigger inflammation in liver failure patients. The trial aims to establish the device's safety and performance in 24 patients across Europe, with plans for an additional study enrolling over 100 patients.
Approval rates climbed steadily from 85% to 95% among privately insured patients, with fewer delays in clearance. The ACA provision required private insurers to cover clinical trial participation, benefiting those with insurance.
According to a revised pipeline analysis, six Alzheimer's drugs will conclude Phase III trials in 2017, bringing much-needed solutions to families in the near future. The late-stage pipeline offers hope to 5.5 million Americans with the disease and their caregivers.
A new study published in JAMA found that giving healthy children high doses of vitamin D during the winter did not reduce the number of colds they got. The study, led by Dr. Jonathon Maguire, involved 700 children who received either a standard or high dose of vitamin D, with no difference in cold frequency between the two groups.
A large-scale trial found that goal-oriented therapy significantly improves people's ability to engage in important daily tasks and maintain independence. The therapy, which involves setting and achieving individual goals, shows promising results for supporting individuals with early-stage dementia to live fulfilling lives.
Researchers found that regularly doing word puzzles like crosswords is linked to better brain function in later life. Participants who engaged with word puzzles performed better on tasks assessing attention, reasoning, and memory.
The Phase 3 clinical trial data showed statistically significant and clinically meaningful improvements in functional vision and visual field in participants with RPE65-mediated inherited retinal disease. Participants demonstrated marked gains in full-field light sensitivity and peripheral vision.
A randomized clinical trial found tramadol extended-release to suppress opioid withdrawal more effectively than clonidine, and similarly to buprenorphine. The study suggests tramadol ER as a promising medication for opioid use disorder treatment, but notes the need for further research.
A new registry study highlights the unique characteristics of heart failure patients in Asia, including younger age and higher co-morbidity rates compared to Western populations. The study also reveals underutilization of potentially life-saving implantable cardiac defibrillators in Asia.
Entinostat inhibits myeloid derived suppressor cells, leading to enhanced antitumor activity when combined with PD-1 blockade. This preclinical study suggests entinostat may provide an effective combination treatment approach for patients with solid tumors.
A cluster randomized factorial trial found that training and support have a lasting impact on primary care clinicians' delivery of screening and advice to heavy drinkers. The study suggests that repeated training and support can lead to an increase in the volume of brief interventions delivered to heavy drinking patients.
Researchers discovered a molecular signature in patients who responded to the anti-asthma drug amlexanox, which showed significant improvements in blood glucose levels. The study reveals a potential new therapeutic approach for treating type 2 diabetes and identifies key gene changes associated with the beneficial effects.
Researchers found no significant difference in pain intensity after radiofrequency denervation, a procedure that uses electric current to target nerve pain sources. The study involved 681 participants and included three randomized clinical trials assessing the effectiveness of the treatment for different types of low back pain.
A randomized double-blind study involving 51 participants found a 68% improvement in slowing whole brain atrophy in patients with secondary progressive MS. Lipoic acid also improved walking times and reduced falls compared to placebo.
A new trial by University of Exeter researchers found that taking low-dose aspirin before bed can reduce the risk of pre-eclampsia, a condition causing premature birth and maternal and foetal death. The study showed a 62% reduction in pre-term preeclampsia rates.
A new CT Perfusion technology has been developed to measure blood flow and predict how well ovarian cancer patients will respond to treatment. The study found that a decrease in blood flow is associated with longer survival times, while an increase is linked to shorter survival times.
A new global health trial found that family-led stroke rehabilitation is ineffective in reducing disability and improving recovery outcomes. The ATTEND trial, published in The Lancet, suggests that effective rehabilitation requires professionals with years of training and specialized expertise.
A £1.5 million study led by the University of Warwick is investigating two biomarkers to guide safe reduction in antibiotic treatment time for patients with suspected sepsis. The trial will compare survival rates, discharge times, and antibiotic usage across three groups.
A phase 1 trial involving 100 people found that a dissolvable microneedle patch for the flu vaccine was safe and acceptable, with participants reporting high acceptability and preferring it over conventional injection. The patches were stable for one year at 40 degrees Celsius, reducing delivery and storage costs.
A phase I clinical trial found that influenza vaccination using microneedle patches was as effective as traditional shots, generating robust immunity against influenza. The patches were well-tolerated, with no adverse events reported, and participants preferred them over traditional vaccination methods.
A pilot randomized trial found that about 22% of generally healthy adult patients with whole genome sequencing results had a previously unrecognized variant with potential risk for a rare Mendelian disease. However, only about 4% had a clinically relevant abnormality related to a variant.
A large trial involving over 11,000 patients reveals that sitting up or lying flat after a stroke makes no difference to their recovery. The study found that good nursing care is more important than head position in determining outcomes.
A new research tool may predict a patient's risk for developing dementia in Parkinson's disease, enabling the design of 'smarter' trials that require fewer participating patients. The tool was built using data from 3,200 people with PD and evaluates seven known clinical and genetic risk factors.
A phase 1 randomized controlled trial found an Ebola virus disease vaccine developed in Canada to be well-tolerated and effective, with high antibodies present six months after immunization. The vaccine showed no safety concerns and was well-received by participants.
A randomized clinical trial of 230 Head Start mothers found that a problem-solving intervention significantly reduced depressive symptom episodes. The study suggests that such interventions can be an effective approach to addressing maternal depression, particularly among vulnerable populations.
Researchers have discovered a solution to evade the immune system, allowing more patients to participate in gene therapy clinical trials. The altered virus can slip past neutralizing antibodies, making it possible for up to 70% of patients previously ineligible to join trials.
Researchers have developed a new sequential multiple assignment randomized (SMART) trial method to test two hypotheses at once. This approach allows for the simultaneous evaluation of different treatments, potentially leading to more accurate results and increased efficiency in clinical trials.
Researchers found that current assessments are not keeping up with clinical trial advances, highlighting the need for improved treatment outcome measurement tools. Most outcome measures in FXS clinical trials received only a moderate rating due to limited information on reliability and validity.
A Wayne State University research team will conduct a five-year trial to test an intervention on tablet computers that helps parents engage in effective parenting to assist their diabetic adolescents complete daily care. The study aims to improve health outcomes and metabolic control among African American youth with Type 1 diabetes.
New international guidelines aim to accurately diagnose dementia with Lewy bodies, a disorder that shares symptoms with Alzheimer's and Parkinson's diseases. The guidelines focus on clinical features and diagnostic biomarkers to establish an accurate diagnosis and improve management of the complex disorder.
The NCI-MATCH precision medicine cancer treatment trial has reached its goal of sequencing the tumors of 6,000 patients two years ahead of schedule. This is due to wide-scale adoption throughout the NCTN and NCORP networks, resulting in an unprecedented rate of patient enrollment.
Recent clinical trials using different gene transfer approaches have shown acceptable risk and potential for treating heart failure with reduced ejection fraction. Despite mixed results in terms of efficacy, the data support further clinical development of this therapeutic strategy.
A study analyzing SWOG clinical trials found that cancer patients in the US have gained a cumulative 3.34 million years of life due to successful therapies. The analysis calculated that an NCI investment of $125 for each year of life saved was sufficient, making it a cost-effective approach.
A Phase 1/2 clinical trial of an experimental Chikungunya vaccine, MV-CHIKV, is underway in the US. The trial aims to assess the safety and immune response of the vaccine in healthy adults.
A new analysis found that nearly three-quarters of patients with advanced cancer could be referred to a targeted treatment based on their tumor's genetic landscape. Genetic sequencing identified anomalies in 11% of patients, including hereditary variations that increase cancer risk.
A novel sarcoma vaccine has shown an escalating immune response in patients, indicating its potential anti-cancer effects. The findings suggest that the vaccine can generate an immune response and stabilize tumors, making it a promising treatment option.
The study aims to determine the factors influencing frog survival and persistence in the wild. The release trial will help pave the way for successful reintroduction programs, as researchers monitor the frogs' behavior, dispersal, and disease resistance.
At ASCO 2017, SWOG investigators reported trials involving more than 10 cancer types and presented results on treatment-resistant metastatic colorectal cancer, breast cancer chemotherapies, high-risk prostate cancer, and the benefits of public funding for cancer research. The group's research has led to the approval of 14 cancer drugs,...